Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4160-4166
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4160
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4160
Figure 1 Ablation margin and micrometastases/microvascular invasion.
Radiofrequency ablation (RFA) therapy is required to ablate the main tumor and its surrounding liver tissues involving micrometastases and microvascular invasion. However, as the tumor get bigger, micrometastases and microcascular invasion frequently occur. Unablated lesions lead to local recurrences after RFA. T: Tumor.
- Citation: Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 2014; 20(15): 4160-4166
- URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4160.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4160